Therapeutic Efficacy and the Impact of the "Dose" Effect of Acupuncture to Treat Sciatica: A Randomized Controlled Pilot Study.

PURPOSE: To investigate the required sample size for and feasibility of a full-scale randomized controlled trial examining the impact of the "dose" effect of acupuncture in treating sciatica. PATIENTS AND METHODS: Fifty-seven patients with sciatica, aged 35-70 years, were recruited and screened. Thirty-one participants were randomly assigned to receive "low-dose" manual acupuncture (MAL) (n= 15) or "high-dose" manual acupuncture (MAH) (n=16). The acupuncture treatment was administered twice weekly for 4 weeks. The primary outcome was the visual analog scale (VAS) score at baseline and after 4 weeks of acupuncture treatment. Secondary outcomes included the Roland Disability Questionnaire for Sciatica (RDQS), the Sciatica Bothersomeness Index (SBI), and the World Health Organization Quality of Life in the Brief Edition (WHOQOL-BREF) scores at baseline and after 4 weeks of acupuncture treatment.
RESULTS: Thirty patients completed the study. For all patients, acupuncture achieved significant improvement in the VAS (5.48±2.0, p<0.001), RDQS (3.18±2.83, p=0.004), and SBI (2.85±3.23, p=0.008) scores, but not in the WHOQOL-BREF scores. In the between-group analysis, the assessed scales showed no significant differences between the MAL and MAH groups. However, based on the level of chronicity, the MAH group demonstrated greater improvement in the outcomes and a significant benefit in the physical subscale of the WHOQOL-BREF (p<0.05).
CONCLUSION: Results of this pilot study indicate that acupuncture is safe and may effectively relieve symptoms and disability in patients with non-acute sciatica. MAL was as effective as MAH in treating sciatica. A subsequent trial with a larger sample size (estimated at n=96) is required to confirm whether patients with a high level of chronicity would benefit from MAH treatment. TRIAL REGISTRATION: NCT03489681.

Introduction

Sciatica is a common and bothersome medical problem. It typically presents as unilateral gluteal pain that may involve one leg in association with motor or sensory disturbances. Chronic sciatica may cause personal morbidity and negatively impact an individual’s quality of life (QOL).1,2 The prevalence of sciatica varies among studies, with incidences of 24–40% for different etiologies.3,4 The most common cause of sciatica is a herniated or bulging lumbar intervertebral disc.5 Other nondiscogenic causes that may contribute to sciatica include bony or muscular compression, vascular anomalies, and epidural adhesion.6 Owing to the diverse origins of sciatica, the most effective treatment for sciatica remains unknown. A recently published guideline (National Institute for Health and Care Excellence [NICE]7) for treating low back pain with or without sciatica suggests administering noninvasive treatments such as physical therapy, yoga, tai chi, or nonsteroidal anti-inflammatory drugs for first-line management of the condition.7 However, the NICE guidelines do not suggest patients with sciatica receive acupuncture treatment due to the relatively low-quality evidence from randomized controlled trials.

Acupuncture has been proposed as a treatment resulting in better outcomes8 for many muscular and neurological diseases such as fibromyalgia, migraines, chronic pain syndrome, and acute stroke.9–13 Acupuncture maneuvers may elicit a sensation of “de qi” (ie, dull pain, soreness or needling sensation) to achieve analgesia: neural signals are transferred through the peripheral nociceptive pathway, leading to a central neuromodulatory effect.14,15

Nevertheless, there are several debates surrounding acupuncture treatment because there is inadequate evidence to promote its routine use.7,12 Some clinical trials and meta-analyses have recently contributed more evidence regarding acupuncture treatment for sciatica.16–18 He et al, in their study of post-partum sciatica, revealed that up to 98% of patients in the treatment group recovered, compared with 24% in the non-acupuncture control group.16 Zhang et al showed electroacupuncture had greater short- and long-term benefits for chronic discogenic sciatica than medium-frequency electrotherapy.17 Qiu et al also demonstrated that acupuncture may stimulate the sciatic nerve trunk and effectively relieve pain in patients with discogenic sciatica.18 Moreover, acupuncture may reduce sciatica pain intensity, increase the pain threshold,19 enhance the effects of drug, and improve outcomes.20,21 The benefits of acupuncture in treating sciatica are well known; however, the possible dose-related response has not been sufficiently explored.22,23

Considering that acupuncture is more effective in treating sciatica than traditional treatments; we investigated the dose effect of acupuncture and observed the impact of pain chronicity. We hypothesized that, if acupuncture therapy is effective for pain relief in chronic sciatica, the number of acupoints (ie, dosage) may have a crucial role in pain relief. We also investigated the efficacy of acupuncture in treating sciatica and the impact of pain duration on treatment outcome.

Patients and Methods

Study Design

This randomized, prospective study enrolled consecutive patients who fulfilled the inclusion criteria. The study was approved by the institutional review board of the Taipei Veterans General Hospital (Taipei, Taiwan) in accordance with the Helsinki Declaration. All patients provided written informed consent. The trial is registered in the US National Institutes of Health trials registry at (registration No. NCT03489681).

The study comprised two parallel arms: (1) the “low-dose” manual acupuncture (MAL) treatment group, which involved six acupoints, and (2) the “high-dose” manual acupuncture (MAH) treatment group, which involved 18 acupoints. All patients received 4 weeks of treatment, twice weekly, for a total of eight sessions of acupuncture treatment. All patients were surveyed using behavioral scales at baseline and 4 weeks after initiating acupuncture treatment.

Patients

Outpatients who met the inclusion criteria were recruited for this study. The selection criteria were: 35–70 years of age, low back or gluteal pain that radiated to one leg, and pain lasting at least 2 weeks. To meet the inclusion/diagnosis criteria, participants had to fulfill least two of the following items: (1) radicular pain in the L4, L5, or S1 dermatome; (2) physical examination results consistent with radicular pain, motor or sensory neurological findings, or decreased reflex in the L4, L5, or S1 spinal nerve roots; (3) positive results on a straight-leg-raise test; (4) increased leg pain upon coughing, sneezing, or straining; and (5) magnetic resonance imaging demonstrating a unilateral disc herniation impinging on the L4, L5, or S1 nerve roots. The exclusion criteria were: history of or suspected serious spinal pathology (eg, cauda equina syndrome or spinal fracture); pregnant or breastfeeding; scheduled or being considered for spinal surgery or interventional procedures for sciatica during the 8-week treatment period; comorbid systemic malignancy, bleeding tendency, rheumatic arthritis, or other known autoimmune diseases; focal neurological deficits with progressive or disabling symptoms; acupuncture treatment within the previous month; contraindications for acupuncture or magnetic resonance imaging; visual analogue scale (VAS) score <3 for sciatica; and low back pain without sciatica.

Randomization Procedures

Patients were randomized using permuted blocks of four with stratification. The generated code was sealed in an envelope until informed consent was obtained. Patients were randomly allocated to the MAL group or the MAH group. The research assistant opened the sealed envelope before the patient’s first acupuncture treatment in the study.

Intervention

Experienced acupuncturists (n = 2) were allocated to alternatively administer treatment to patients in the MAL and MAH groups. Patients in the MAL group received treatment on six acupoints, as follows: Shenshu (BL 23), Huantiao (GB 30), Weizhong (BL 40), Yanglingquan (GB 34), Kunlun (BL 60), and Xuanzhong (GB 39). Patients in the MAH group received 18 acupoints as follows: Shenshu (BL 23), Dachangshu (BL 25), Xiaochangshu (BL 27), Huantiao (GB 30), Yinmen (BL 37), Zhibian (BL 54), Chengfu (BL 36), Fengshi (GB 31), Weizhong (BL 40), Zusanli (ST 36) Yanglingquan (GB 34), Yinlingquan (SP 9), Feiyang (BL 58), Sanyinjiao (SP 6), Xuanzhong (GB 39), Kunlun (BL 60), Taixi (KI 3), and Shenmai (BL 62). Acupoint selection was based on previous treatment experience and traditional Chinese medicine (TCM) theory, all selected points were practically effective for treatment.24 We also took into consideration sciatica dermatomes when choosing acupoints.

Sterile disposable 0.3 mm × 40 mm or 0.35 mm × 50 mm (diameter × length) stainless steel needles (Ching Ming Medical Device Co, Taipei, Taiwan, ROC) were used. Needles were used only once and were generally inserted to a depth of 5–30 mm, depending on the acupoint. Insertion was followed by manual stimulation to elicit the “de qi” sensation. Needles were retained in position for 20–30 mins.

Outcome Measures

The primary outcome was the 10-cm VAS score for sciatica, which was measured at baseline and week 4. The patients rated their average leg pain over the previous 24 hrs from 0 (ie, “no leg pain”) to 10 (ie, “worst pain imaginable”).25,26

There were several secondary outcomes. The Roland Disability Questionnaire for Sciatica (RDQS) score,1,27 measured at baseline and week 4, was used to assess functional disability; the scores ranged from 0 (ie, “no disability”) to 24 (ie, “most disability”) with higher values indicating worse outcomes. The Sciatica Bothersomeness Index (SBI) was used to rate leg pain and other bothersome symptoms such as paresthesia and weakness, with scores ranging from 0 (ie, “not bothersome”) to 24 (ie, “extremely bothersome”); higher symptom scores were associated with higher emotional distress and lower physical function.28,29 The World Health Organization Quality of Life in the Brief Edition (WHOQOL-BREF) was scored at baseline and at week 4 to evaluate medical outcomes and QOL. Higher scores indicated a better QOL. The WHOQOL-BREF had four subscales: (1) physical domain (score range, 4–20); (2) psychological domain (score range, 4–20); (3) social domain (score range, 4–20); and (4) environmental domain (score range, 4–20). The total score ranged from 8 to 80 points, with higher values indicating better outcomes.30

During the acupuncture treatment period, the investigative team monitored safety. The physicians and nursing team recorded patients’ vital signs and monitored them for any discomfort. The participants recorded unexpected events that occurred during treatment.

Statistical Analysis

Data are presented as the mean ± standard deviation (SD). We used the Shapiro–Wilk test to determine whether the data exhibited a normal distribution. We used the χ2 test to determine whether the nominal variables were comparable. Between-group differences were assessed using the independent t-test or the nonparametric Mann–Whitney U-test, based on the normality test findings. The primary and secondary outcome results were analyzed using univariate analysis of variance (ANOVA). We also applied repeated-measures ANOVA to examine changes over time in the primary and secondary outcomes. To assess the improvement rate, we used the independent t-test to compare changes in scores from baseline to 4 weeks after acupuncture treatment. IBM SPSS software v20.0 (Armonk, New York, USA) was used for all statistical analyses. A value of p<0.05 was considered statistically significant, and p<0.1 represented a statistical tendency toward a significant difference.

Results

Participants

From December 2017 to January 2019, 280 patients were assessed for eligibility. Of these, 57 patients were screened (22 men, 35 women). Twenty-six patients (11 men, 15 women) were excluded for the following reasons: declined to participate (n=8); had low back pain only (n=5); had major cardiovascular disease (n=1); VAS score <3 (n=4); acupuncture treatment within the preceding month (n=2); immunocompromised status (n=1); acute sciatica (n=3); fear of acupuncture (n=1), and history of lumbosacral operation (n=1). Of the remaining 31 patients, 16 were allocated to the MAH group, and 15 to the MAL group (Figure 1). After one dropout, 30 participants were included in the study (11 men and 19 women).

Figure 1

Patient flowchart diagram.

Abbreviations: VAS, visual analog scale; M, male patient; F, female patient; MAH, “high-dose” manual acupuncture treatment group; MAL, “low-dose” manual acupuncture treatment group.

Baseline Characteristics

The average age of all recruited participants was 58.73±12.14 years. The average sciatica pain duration was 25.67±23.67 months. The average baseline VAS, SBI, RDQS, and WHOQOL-BREF scores were 6.09±1.73, 13.33±5.12, 10.60±4.64, and 53.97±8.27, respectively (). The effectiveness of acupuncture treatment did not seem to differ between the sexes (). The mean age was 63.20±8.20 years in the MAH group and 54.27±14.97 years in the MAL group (p=0.042). Sex, lateralization of sciatica, and pain duration did not differ significantly between the two groups. The intergroup baseline scores were not significantly different (Table 1).

Table 1

Clinical Characteristics at Baseline and During the Treatment Phase in the Different Dose Groups

Characteristic	MAH (n=15)		MAL (n=15)		p-valueb
	Baseline	Treatmenta	Baseline	Treatmenta	Baseline	Treatment
Gender (M/F)	7/8		4/11		0.450
Age (y)	63.20±8.20		54.27±14.97		0.042*
Duration (mo.)	22.67±22.19		28.67±25.47		0.497
Side (right/left)	8/7		6/9		0.715
VAS	5.90±1.74	3.94±2.51*	6.29±1.76	4.00±1.95**	0.546	0.942
SBI	13.47±5.51	10.73±5.74	13.20±4.89	9.47±3.83*	0.890	0.484
RDQS	11.13±4.03	9.33±4.86	10.07±5.26	6.20±5.27*	0.538	0.102
WHOQOL-BREF	53.00±8.31	54.27±8.22	54.93±8.40	55.23±7.07	0.532	0.735
Physical	12.38±1.93	13.29±2.44	13.07±2.43	13.87±1.76	0.399	0.467
Psychological	13.29±2.59	13.24±2.29	13.28±2.47	13.55±2.22	0.997	0.708
Social	13.33±2.81	13.33±3.07	14.58±2.33	13.74±2.49	0.197	0.695
Environmental	14.00±2.22	14.04±1.79	14.00±2.18	14.07±2.02	1.000	0.636

Notes: Data are presented as the mean ± the standard deviation (SD). The data were compared using the nonparametric Mann–Whitney U-test (for continuous variables). aTreatment, within-group p-value. bp-value, between-group p-value. *p<0.05; **p<0.01.

Abbreviations: MAH, “high-dose” manual acupuncture; MAL, “low-dose” manual acupuncture; VAS, visual analog scale; SBI, Sciatica Bothersomeness Index; RDQS, Roland Disability Questionnaire for Sciatica; WHOQOL-BREF, World Health Organization Quality of Life in the Brief Edition.

VAS Score

Based on the within-group analysis of changes from the baseline values in each group, the VAS scores for the MAL and MAH groups were significantly reduced after 4 weeks of acupuncture treatment (from 5.90±1.74 to 3.94±2.51, p<0.05 [MAL]; from 6.29±1.76 to 4.00±1.95, p <0.005 [MAH]). On combining the two groups, the VAS score changed from 6.09±1.73 at baseline to 3.97±2.21 after initiating acupuncture treatment (p=0.000; Table 1). However, there were no significant differences between the VAS scores of the MAH and MAL groups at 4 weeks (Table1).

Other Outcomes

The SBI and RDQS scores for all participants were significantly different after acupuncture treatment (p<0.05; ). Only the MAL group had a significant improvement in SBI and RDQS scores (p<0.05; Table 1 and Figure 2). WHOQOL-BREF scores did not differ significantly within either group.

Figure 2

Outcome measures in the two dose groups before and after acupuncture treatment.

Abbreviations: MAH, “high-dose” manual acupuncture treatment group; MAL, “low-dose” manual acupuncture treatment group; SBI, Sciatica Bothersomeness Index; RDQS, Roland Disability Questionnaire for Sciatica; VAS, visual analog scale; Acup, acupuncture; *p<0.05; **p<0.01.

Sample-Size Calculation

The SD values of the primary end point (VAS) were used to calculate the sample size for a future definitive trial using G*Power V.3.1.9.2 (Heinrich-Heine University of Dusseldorf, Düsseldorf, Germany). The change in VAS score between baseline and 4 weeks was selected as the most suitable primary outcome for sample-size calculation. The mean square of the residual of the VAS scores of all patients after baseline VAS score adjustment was estimated to be 2.52, which was converted to an SD of 1.66. Assuming this degree of variance, 42 patients per group would be required to detect an effect size of 0.55 at a 5% significance level with 80% power. To allow for an 18% loss to follow-up (based on our results), a full-scale study would require 96 patients in total.

Acupuncture Effect on the Chronicity of Pain

Subgroup analysis was used to assess the patients completed the study, based on pain duration: the nonchronic pain (NCr) group patients (n= 14) had a pain duration of ≤12 months; the chronic pain (Cr) group patients (n= 16) had a pain duration of >12 months. Nearly all outcome measure scales were “severe” before acupuncture in the Cr group when compared with those of the NCr group (Table 2). There were significant differences in the scores of the WHOQOL-BREF and its subscales (Figure 3A and B). After acupuncture treatment, the between-group difference (ie, NCr vs Cr) showed a decreasing trend (Table 3 and Figure 3C). With regard to the effect of dose on chronicity, the physical subscale of the WHOQOL-BREF significantly improved in the Cr group after MAH (Figure 3D).

Table 2

Clinical Characteristics at Baseline in Groups with Differing Chronicity

Characteristics	NCr (n=14)	Cr (n=16)	p-value
Sex (M/F)	6/8	5/11	–
Age (y)	62.86±9.05	55.12±13.57	0.081
Body mass index	25.78±3.79	25.15±3.51	0.642
Pain duration (mo.)	4.43±3.65	44.25±16.81	0.000**
VAS	6.40±1.92	5.82±1.55	0.364
SBI	12.57±6.32	14.00±3.88	0.456
RDQS	9.64±5.21	11.43±4.05	0.298
WHOQOL-BREF, total	58.16±9.63	50.30±4.58	0.007**
Physical	13.47±2.73	12.07±1.33	0.08
Psychological	14.57±2.87	12.17±1.39	0.006**
Social	15.05±2.79	13.00±2.09	0.03*
Environmental	15.07±2.34	13.06±1.50	0.009**

Notes: The data are presented as the mean ± the standard deviation (SD). Data were compared using the independent t-test (for continuous variables). *p<0.05; **p<0.01.

Abbreviations: NCr, nonchronic sciatica group (pain duration, ≤12 months); Cr, chronic sciatica group (pain duration, >12 months); VAS, visual analog scale; SBI, Sciatica Bothersomeness Index; RDQS, Roland Disability Questionnaire for Sciatica; WHOQOL-BREF, the World Health Organization Quality of Life in the Brief Edition.

Figure 3

Impact of acupuncture treatment on various outcome measures at different levels of sciatica chronicity. (A) The total score of the WHOQOL-BREF scales before and after acupuncture treatment in sciatica groups with different levels of chronicity. (B) The four domains of the WHOQOL-BREF before and after acupuncture treatment in sciatica groups with different levels of chronicity. (C) Various outcome measures before and after acupuncture treatment in sciatica groups with different levels of chronicity. (D) The physical domain of the WHOQOL-BREF before and after acupuncture treatment at the two doses in sciatica groups with different levels of chronicity.

Abbreviations: WHOQOL-BREF, World Health Organization Quality of Life in the Brief Edition; NCr, nonchronic sciatica group (pain duration, ≤12 months); Cr, chronic sciatica group (pain duration, >12 months); Phy, physical domain of the WHOQOL-BREF; Psy, psychological domain of the WHOQOL-BREF; Soc, social domain of the WHOQOL-BREF; Evn, environment domain of the WHOQOL-BREF; MAH, “high-dose” manual acupuncture treatment group; MAL, “low-dose” manual acupuncture treatment group; SBI, Sciatica Bothersomeness Index; RDQS, Roland Disability Questionnaire for Sciatica; VAS, visual analogue scale; Acup, acupuncture; *p<0.05; **p<0.01.

Table 3

Clinical Outcomes After Acupuncture in Groups with Differing Chronicity

Characteristics	NCr (n=14)	Cr (n=16)	p-value
VAS	4.46±2.47	3.58±1.92	0.266
SBI	10.00±4.66	10.19±5.14	0.918
RDQS	7.79±5.81	7.75±4.86	0.986
WHOQOL-BREF, total	57.41±7.42	52.42±4.08	0.071
Physical	13.92±2.40	13.29±1.95	0.421
Psychological	14.24±1.93	12.67±2.26	0.052
Social	14.29±2.74	12.88±2.68	0.167
Environmental	14.96±1.94	13.59±1.64	0.045*

Notes: The data are presented as the mean ± the standard deviation (SD). Data were compared using the independent t-test (for continuous variables). *p<0.05.

Abbreviations: NCr, nonchronic sciatica group (pain duration, ≤12 months); Cr, chronic sciatica group (pain duration, >12 months); VAS, visual analog scale; SBI, Sciatica Bothersomeness Index; RDQS, Roland Disability Questionnaire for Sciatica; WHOQOL-BREF, the World Health Organization Quality of Life in the Brief Edition.

Adverse Events

No serious adverse events occurred. One patient in the MAL group felt transient dizziness during acupuncture.

Discussion

The present study aimed to investigate the effectiveness of acupuncture therapy on chronic sciatica, the dose effect of acupuncture, and the influence of pain chronicity on acupuncture treatment outcome. First, we observed whether acupuncture was effective in patients with sciatica who received MAL or MAH. Second, we found that the efficacy of acupuncture treatment on sciatica was not lesser in the MAL group than in the MAH group. Third, the analysis of sciatica pain chronicity revealed that patients who had sciatica for more than 12 months had inferior scores for pain or disability than patients who had sciatica for less than 1 year. Fourth, we demonstrated that acupuncture may ameliorate differences between groups with different levels of pain chronicity, and we further specified that MAH may enhance physical activity in patients with a relatively longer pain duration.

The results of this study indicated that, in patients with chronic sciatica, acupuncture therapy was effective for pain relief, reduced disability, and alleviated annoyance due to sciatica. Our results are in line with those of recent clinical trials and meta-analyses.16,19,20,31 In our previous review of common acupoints for treating sciatica,24 the acupoints selected were primarily in the bladder (BL) and gallbladder (GB) meridians, as well as the Governing Vessels and Kidney (KI) meridians, which, based on TCM theory, may nourish the patient’s qi. Our acupoint selection for treating sciatica was based on TCM theory and took into account a concept in contemporary medicine: the dermatome. Sciatica primarily involves the L4 and L5 to S1 dermatomes.2,32 The BL and GB meridians are mostly distributed in the L4, L5, and S1 dermatomes, and the KI, stomach (ST) and spleen (SP) meridians are generally distributed in the L4 and S1 dermatomes. Recent research reveals that acupuncture stimulation in the sciatic nerve trunk is more effective in relieving pain compared with simple routine acupuncture.18 Our strategy for choosing acupoints seems to reflect the efficacy of acupuncture treatment for sciatica.

The concept of acupuncture “dose” is varied and generally includes needling depth, intensity, “de qi” sensation, and treatment frequency.33–35 The Delphi Consensus on the assessment of the quality of acupuncture declared that treatment components such as the number of needles, type of stimulation, retention time, and number of treatments all contribute to the “dose” of acupuncture.36 In the current study, we used number of needles (ie, acupoints) applied to the ipsilateral meridians in the same dermatomes of the sciatic nerve to characterize the dosage of acupuncture and found that MAL was as efficient as MAH after 8 sessions of acupuncture treatment, which is line with a previous study on the “dose” of acupuncture for treating a painful cervical myofascial syndrome.37 Similar dose-finding studies reveal that changing in modes of stimulation such as whether to apply manual stimulation and the frequency of manipulation did not result in significant differences in the treatment of fibromyalgia or menstrual pain, respectively.33,38 However, a meta-analysis on treating primary dysmenorrhea with acupuncture showed that needle location, number of needles used, and frequency of treatment may have dose–response relationships with menstrual pain outcomes.23 A contradictory dose–response relationship can be attributed to the variable aspect of the “dose” of acupuncture, which involves both the physiological effects of needling and a patient’s perception.35

Chronic pain involves multidimensional aspects such as biological, psychological, and social facets that determine a patient’s experience of pain.39 The chronicity of pain may be associated with clinicians’ inability to manage pain effectively.40 Our study did not reveal a difference in treating sciatica in the MAL group or MAH group; nevertheless, we tried to specify further whether the dose–response relationship may be correlated with the chronicity of pain.

Our results demonstrated that the Cr group had significantly lower scores on the WHOQOL-BREF and its physical, social, and environmental subscales than the NCr group. Acupuncture may enhance QOL in multifaceted ways and narrow the gap between groups of individuals with different levels of chronicity. With regard to the dose–response effect, the MAH group demonstrated a significant improvement in the physical subscale of WHOQOL-BREF when compared with the MAL group.

In the previous research, the stage of chronicity was an important attribution of psychological vulnerability for pain-related disability,41 and higher stages of chronicity require a multidisciplinary treatment strategy to provide a benefit.42 In our study, MAH involved more acupoints/meridians (ie, BL, GB, ST, and SP) than MAL (ie, BL and GB). This factor may ensure that individuals receiving MAH achieve a greater multilevel therapeutic benefit from peripheral nociception to the central analgesic effect of the brain.43

This study demonstrates a dose–response relationship of acupuncture for treating sciatica and presents a relationship between MAH and the stage of chronicity. A potential implication of our results is that, in treating chronic pain, acupuncturists may choose different dosages (ex, six vs. 18 acupoints) according to the pain chronicity of the patients.

However, there are some limitations to our study. Acupuncture in clinical trials cannot be conducted with a double-blind design, and using sham needles has a placebo effect.44,45 In the current study, we did not assign a placebo group because of ethical reasons and because we wanted to observe the dose-response in real-world acupuncture practice. Moreover, our study did not has blinded observers to measure treatment outcomes because pain or disability for sciatica is relative to each patient, and the questionnaire could be filled out only by the patients. Furthermore, as the study involved a relatively small sample size, further research with a larger sample size is needed to investigate the impact of acupuncture “dose” on the level of pain chronicity in multidimensional aspects of pain perception.

Conclusion

Results of this prospective, randomized, controlled, pilot study suggests that acupuncture is safe and effective for relieving symptoms and disability in patients with non-acute/chronic sciatica. MAL is as effective as MAH in treating chronic sciatica. MAH treatment seems superior to MAL treatment for sciatica patients with a higher stage of chronicity. However, more extensive case-control studies with larger sample sizes are needed to confirm with better certainty a dose–response relationship and the impact on chronicity.